Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
Clinical trial NCT06670352 · COMPLETED
Trial details
- NCT number
- NCT06670352
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-12
- Primary completion
- 2025-12-20
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.